This list is an analysis based on recent market events. It's not an investment recommendation.
About
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
The current price of EVE.AU is A$0.03 AUD — it has increased by +0% in the past 24 hours. Watch EVE Health Group stock price performance more closely on the chart.
What is EVE Health Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange EVE Health Group stocks are traded under the ticker EVE.AU.
What is EVE Health Group market cap?▼
Today EVE Health Group has the market capitalization of 8.26M
What is EVE Health Group revenue for the last year?▼
EVE Health Group revenue for the last year amounts to 5.38M AUD.
What is EVE Health Group net income for the last year?▼
EVE.AU net income for the last year is -4.88M AUD.
In which sector is EVE Health Group located?▼
EVE Health Group operates in the Finance & Payments sector.
When did EVE Health Group complete a stock split?▼
The last stock split for EVE Health Group was on June 02, 2025 with a ratio of 1:40.
Where is EVE Health Group headquartered?▼
EVE Health Group is headquartered in Subiaco, Australia.